Post-market validation of the Beijing Genomics Institute (BGI) SARS-CoV-2 Real Time PCR platform

This report presents the results of post-market validation of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit.

The Peter Doherty Institute for Infection and Immunity has completed a validation study of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit and associated instrumentation and reagents.

Post-market validation of the Beijing Genomics Institute (BGI) SARS-CoV-2 Real Time PCR platform

About this resource

Publication date:
Publication type:
Report
Audience:
General public
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.